ASXC CHANCE to make X200 Just buy more ASXC. Long time trade. Maybe a years. But I am will be waiting X200 to my order.
−0.3162USD
−78.43 MUSD
8.58 MUSD
266.67 M
About Asensus Surgical, Inc.
Sector
Industry
CEO
Anthony Fernando
Website
Headquarters
Durham
Employees (FY)
209
Founded
1988
ISIN
US04367G1031
FIGI
BBG000C1XKW7
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.
Asensus Surgical Price movementStrong Support: ASXC presents a strong buying opportunity.
Market Structure: The daily chart exhibits an inverse head and shoulders pattern.
Key Support Level: There is robust support at $0.27. If we close below this level, there's a significant risk of a sharp decline toward $0.18.
Major Resista
ASXC Long term channelEven during the recent high volatility, the long term trend remains very bullish.
Consolidation + leg upCurrently consolidating previous gains.
Probably will reach another high after next week.
SL: 0.8
Stock ideaAsensus Surgical (ASXC) potential positive swing with limited downside risk but high upside potential. ASXC announced today the installation of a Senhance® Surgical System in the General Surgery Department of Evangelical Hospital Goettingen-Weende of Göttingen, Germany. This is one of the agreements
Potential Basing Pattern in Asensus SurgicalMy other interpretation is slightly less bullish but still has upside to around $20. This also could be a countertrend interruption to the long term bearish price action which would lead to the stock getting delisted. I see a lot of opportunity here and if this basing pattern holds profits will be i
ASXC Ready to make a big move 50%+ and 5x still in PlayCalling a bottom on this one has proven to be difficult, Volume is pretty much non existent and ready for a spike. I am Bullish
#CEDA $ASXC Forecast AnalysisThis is the Forecast of $ASXC Company
DISCLAIMER: I am not a financial advisor. All content provided on this channel, and my other social media channels/videos/podcasts/posts, is for entertainment purposes only and reflects my personal opinions. Please do your own research and talk with a financi
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ASXC is 0.2512 USD — it has decreased by 0.59% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Asensus Surgical, Inc. stocks are traded under the ticker ASXC.
Asensus Surgical, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ASXC stock is 4.38% volatile and has beta coefficient of 0.83. Check out the list of the most volatile stocks — is Asensus Surgical, Inc. there?
One year price forecast for Asensus Surgical, Inc. has a max estimate of 0.3500 USD and a min estimate of 0.3500 USD.
ASXC earnings for the last quarter are −0.06 USD per share, whereas the estimation was −0.07 USD resulting in a 14.29% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about Asensus Surgical, Inc. earnings.
Asensus Surgical, Inc. revenue for the last quarter amounts to 1.09 M USD despite the estimated figure of 1.99 M USD. In the next quarter revenue is expected to reach 5.45 M USD.
Yes, you can track Asensus Surgical, Inc. financials in yearly and quarterly reports right on TradingView.
ASXC stock has fallen by 8.99% compared to the previous week, the month change is a 12.17% fall, over the last year Asensus Surgical, Inc. has showed a 67.06% decrease.
ASXC net income for the last quarter is −17.24 M USD, while the quarter before that showed −18.32 M USD of net income which accounts for 5.91% change. Track more Asensus Surgical, Inc. financial stats to get the full picture.
Today Asensus Surgical, Inc. has the market capitalization of 68.73 M, it has increased by 24.27% over the last week.
No, ASXC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ASXC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Asensus Surgical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 209.00 employees. See our rating of the largest employees — is Asensus Surgical, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Asensus Surgical, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Asensus Surgical, Inc. stock shows the sell signal. See more of Asensus Surgical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Asensus Surgical, Inc. future price: according to them, ASXC price has a max estimate of 0.35 USD and a min estimate of 0.35 USD. Read a more detailed Asensus Surgical, Inc. forecast: see what analysts think of Asensus Surgical, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Asensus Surgical, Inc. EBITDA is −74.40 M USD, and current EBITDA margin is −867.45%. See more stats in Asensus Surgical, Inc. financial statements.